Merck disclosed an equity stake in Evaxion and licensed its AI-guided vaccine candidate EVX-B3.
This extends Merck's AI use beyond traditional pharma and mRNA oncology.
The move supports its goal of building more than 20 growth drivers.
What happened
Merck disclosed an equity stake in Evaxion A/S tied to an AI-powered vaccine program centered on candidate EVX-B3, and licensed EVX-B3 as part of its push into AI-driven vaccine discovery.
Why it matters
This move extends Merck's use of AI beyond traditional pharmaceuticals and mRNA oncology research, aligning with its strategy to build more than 20 potential growth drivers to offset future KEYTRUDA exclusivity risk.
What to watch
Investors should watch whether EVX-B3 progresses into and through clinical trials with clear timelines and disclosed study designs, including updates on patient enrollment, safety data, and movement into later phases.
Ask the AI about this article →
Merck's equity stake in Evaxion and the licensing of EVX-B3 signal a deliberate expansion of its AI-driven discovery playbook. The company is already partnering with Moderna on an mRNA cancer therapy that met key trial endpoints, and this new move into AI-supported vaccine design builds on that momentum. The strategic context is clear: Merck aims to build a pipeline of more than 20 potential growth drivers to cushion against future KEYTRUDA exclusivity risk, and AI-driven vaccine discovery is one avenue to achieve that. Investors should watch for concrete clinical milestones for EVX-B3, such as trial progress and safety data, to gauge execution.
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytime
Ask AI anything about this article. Q&As are published on this page for other readers too.
Novo Nordisk has entered a strategic partnership with Amazon Web Services, making AWS its preferred cloud prov…
A Las Vegas tourist tried to avoid OYO but says a fake AI hotel listing led her there anyway
Verizon Communications (NYSE: VZ) launched an exclusive Google Pixel 11 lineup, plus new Simplicity and Simpli…
Nucleai announced an ongoing translational research collaboration with Gilead Sciences, using AI-driven tissue…
North America's Building Trades Unions, BlackRock, and the AI Infrastructure Partnership signed a Memorandum o…
Texas Governor Greg Abbott said data centers “dug their own grave,” according to Axios, signaling a shift in t…
